La Paz University Hospital-IdiPAZ Trials

La Paz University Hospital-IdiPAZ	Welcome, Profile Billing Logout

La Paz University Hospital-IdiPAZ

Welcome, Profile Billing Logout

5 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Kimmig, Rainer

CRANIO4US, NCT04319510: Supportive Effects of Craniosacral Therapy for Female Patients With Breast Cancer and Their Partners

Active, not recruiting

N/A

102

Europe

Craniosacral therapy, Craniosacral self-help group training, Treatment as usal / wait list

Universität Duisburg-Essen

Breast Cancer, Complementary Therapies

07/25

12/25

NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting

N/A

212

Europe, Canada, US, RoW

Non-Interventional Study

Mayo Clinic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023

10/29

PMMR, NCT04504006: European Collaborative Multicenter Observational Study: Modular Treatment With and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

Recruiting

N/A

500

Europe

Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

Dr. Paul Buderath

Endometrial Cancer

01/25

01/30

Buderath, Paul

NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting

N/A

212

Europe, Canada, US, RoW

Non-Interventional Study

Mayo Clinic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023

10/29

Recruiting

N/A

500

Europe

Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

Dr. Paul Buderath

Endometrial Cancer

01/25

01/30

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Kimmig, Rainer

CRANIO4US, NCT04319510: Supportive Effects of Craniosacral Therapy for Female Patients With Breast Cancer and Their Partners

Active, not recruiting

N/A

102

Europe

Craniosacral therapy, Craniosacral self-help group training, Treatment as usal / wait list

Universität Duisburg-Essen

Breast Cancer, Complementary Therapies

07/25

12/25

NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting

N/A

212

Europe, Canada, US, RoW

Non-Interventional Study

Mayo Clinic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023

10/29

Recruiting

N/A

500

Europe

Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

Dr. Paul Buderath

Endometrial Cancer

01/25

01/30

Buderath, Paul

NCT06689956: Outcomes of Low-Risk Endometrial Cancer with Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective, Multicenter, Cohort Study

Recruiting

N/A

212

Europe, Canada, US, RoW

Non-Interventional Study

Mayo Clinic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023

10/29

Recruiting

N/A

500

Europe

Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

Dr. Paul Buderath

Endometrial Cancer

01/25

01/30

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites